PT Merck Tbk (ISX:MERK) YoY EBITDA Growth : -41.53% (As of Mar. 2025)

View and export this data going back to 1981. Start your Free Trial

What is PT Merck Tbk YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. PT Merck Tbk's YoY EBITDA Growth for the quarter that ended in Mar. 2025 was -41.53%.

PT Merck Tbk's EBITDA per Share for the three months ended in Mar. 2025 was Rp45.74.

PT Merck Tbk YoY EBITDA Growth Historical Data

The historical data trend for PT Merck Tbk's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PT Merck Tbk YoY EBITDA Growth Chart

PT Merck Tbk Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

YoY EBITDA Growth

Get a 7-Day Free Trial

-7.80

68.24

22.88

-13.57

-3.77

PT Merck Tbk Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
YoY EBITDA Growth	Get a 7-Day Free Trial															-44.09	-46.68	-20.49	168.08	-41.53

PT Merck Tbk YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

PT Merck Tbk's YoY EBITDA Growth for the fiscal year that ended in Dec. 2024 is calculated as:

	YoY EBITDA Growth (A: Dec. 2024 )
=	(EBITDA per Share (A: Dec. 2024 )	-	EBITDA per Share (A: Dec. 2023 ))	/	\| EBITDA per Share (A: Dec. 2023 ) \|
=	(463.809	-	481.964)	/	\| 481.964 \|
=	-3.77 %

PT Merck Tbk's YoY EBITDA Growth for the quarter that ended in Mar. 2025 is calculated as:

	YoY EBITDA Growth (Q: Mar. 2025 )
=	(EBITDA per Share (Q: Mar. 2025 )	-	EBITDA per Share (Q: Mar. 2024 ))	/	\| EBITDA per Share (Q: Mar. 2024 )) \|
=	(45.737	-	78.221)	/	\| 78.221 \|
=	-41.53 %

PT Merck Tbk YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of PT Merck Tbk's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

PT Merck Tbk Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PT Merck Tbk (ISX:MERK) » Definitions » YoY EBITDA Growth

Comparable Companies

Traded in Other Exchanges

N/A

Address

Jalan T.B. Simatupang No. 8, Pasar Rebo, Jakarta Timur, IDN, 13760

Website

https://www.merck.co.id

PT Merck Tbk engages in the manufacture and sale of pharmaceutical products in Indonesia. The company operates in three segments: Biopharma, Consumer Health, and Others. The company offers pharmaceutical and biological prescription medicines for colorectal cancer, head and neck tumors, multiple sclerosis, infertility, growth hormone disorders, cardiovascular disorders, diabetes, as well as thyroid disorders such as hypothyroidism.

PT Merck Tbk Headlines

No Headlines